CRISPR THERAPEUTICS AG financial statements, including revenue, expenses, profit, and loss

The total revenue of CRSP/N for the last quarter is 9.48 M MXN, and it's 13.53% higher compared to the previous quarter. The net income of Q2 24 is -2.32 B MXN.